Physician

Derek Powell, M.D.

According to 2025 Medicare claims, Derek Powell, M.D. (NPI: 1356650907) practices internal medicine in the Weirton-Steubenville, WV-OH market, with the plurality of this provider's patient population coming from Jefferson, OH. This provider's primary affiliated billing organization is TRINITY WEST (NPI: 1043234677; TIN: 34-0875691) and primary practice location at 43953-3742. Powell is affiliated with the ACO West Virginia (ACO ID: A3563), participating under the MSSP model.

Powell's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 427 traditional Medicare patients, billed 1,156 HCPCS/CPT codes, and received $82,455 in Medicare payments. The top billing code was G0439 (Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit). Part D data shows 17,445 prescription claims across 960 beneficiaries totaling $1,569,537 in drug costs, led by Eliquis (Apixaban). DME data shows 705 claims. Open Payments data shows 123 records totaling $2,575. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have risen steadily, from $713,579 to $1,569,537. For DME billing, reported payments moved from a lower plateau to a higher plateau, from $17,350 to $40,886.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	577	1,857	$109,039
2016	632	2,129	$113,157
2017	502	1,931	$94,332
2018	464	1,848	$99,709
2019	534	2,090	$116,037
2020	536	1,631	$79,701
2021	556	1,699	$121,301
2022	492	1,277	$88,790
2023	422	1,251	$86,773
2024	427	1,156	$82,455

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	565	11,628	$713,579
2016	737	16,771	$1,013,514
2017	724	18,061	$1,212,806
2018	690	17,449	$1,387,364
2019	777	17,573	$1,634,844
2020	858	18,694	$1,691,673
2021	952	20,189	$1,876,626
2022	936	19,912	$2,183,365
2023	975	19,108	$2,078,350
2024	960	17,445	$1,569,537

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	47	274	$13,241
2016	87	553	$13,543
2017	78	521	$8,956
2018	108	592	$21,693
2019	116	613	$20,353
2020	131	689	$51,247
2021	112	695	$44,164
2022	79	833	$67,556
2023	75	719	$79,616
2024	33	705	$58,748

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G0439	Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit	104	104	$121
99309	Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes	95	191	$77
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	228	425	$73
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	124	150	$53
99308	Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, 20 minutes or more	64	134	$50

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	174	7,308	$142,536
Farxiga	Dapagliflozin Propanediol	129	6,761	$128,222
Ozempic	Semaglutide	81	3,777	$125,488
Rybelsus	Semaglutide	69	3,030	$90,399
Jardiance	Empagliflozin	110	4,275	$85,032

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J7677	Revefenacin inhalation solution, fda-approved final product, non-compounded, administered through dme, 1 microgram	N	N/R	30	$22,654
A6021	Collagen dressing, sterile, size 16 sq. in. or less, each	N	N/R	12	$9,447
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	80	$5,681
A6196	Alginate or other fiber gelling dressing, wound cover, sterile, pad size 16 sq. in. or less, each dressing	N	N/R	20	$5,313
J7605	Arformoterol, inhalation solution, fda approved final product, non-compounded, administered through dme, unit dose form, 15 micrograms	N	N/R	44	$2,855

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	123	$2,575	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Derek Powell, M.D.?

Tedicare shows public-source Medicare data for Derek Powell, M.D. (NPI 1356650907), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Derek Powell, M.D. have ACO affiliation data?

Derek Powell, M.D. is shown with ACO affiliation data for ACO West Virginia (MSSP, ACO ID A3563).

What billing organization is linked to Derek Powell, M.D.?

Derek Powell, M.D. is linked to TRINITY WEST (billing NPI 1043234677) in the available physician profile data.

Does Derek Powell, M.D. have Open Payments data?

Derek Powell, M.D. has 123 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.